Brian Gielen

Brian advises clients on a broad range of domestic and cross-border corporate law matters, including public and private M&A, venture capital and private equity investments, as well as capital markets transactions. He advises on other general corporate law matters, such as corporate governance and corporate restructuring. He works with companies in a variety of sectors and industries.

Capital markets transactions

• Advised Sequana Medical, a Belgian pharmaceuticals company, on a private placement for an amount of EUR 11.5 million in gross proceeds.
• Advised MDxHealth, a Belgian pharmaceuticals company, on the registered public offering for total gross proceeds of USD 43 million.
• Assisted Mithra Pharmaceuticals, a Belgian pharmaceuticals company, on the accelerated access to a new tranche of the amended loan facility concluded with funds managed by Highbridge Capital Management, LLC and funds managed by Whitebox Advisors, LLC for an amount of EUR 12,5 million.
• Advised Mithra Pharmaceuticals, a Belgian pharmaceuticals company, on a private placement for an amount of EUR 20 million in gross proceeds.
• Advised MDxHealth, a Belgian pharmaceuticals company, on the registered public offering for total gross proceeds of USD 40 million.

Private equity transactions

• Advised Fortino Capital Growth PE II, a Belgium-based private equity firm, on various capital increases.
• Advised Duodev 2, a Belgium-based private equity firm, on various capital increases.
• Advised Newton Biocapital II, a Belgium-based private equity firm, on various capital increases.
• Advised Spanish private equity firm Asabys Partners on its participation in a EUR 17 million series A financing round in Augustine Therapeutics.
• Advised ATB Therapeutics on a EUR 15 million series A financing round.
• Advised Augustine Therapeutics on its EUR 80 million extended series A financing round.

Public M&A transactions

• Advised Gimv NV regarding the acquisition of the stake of the Flemish Participation Company by SD Worx at a transaction value of EUR 375 million.

Private M&A transactions

• Advised Culligan International Company on its acquisition of Sip-Well NV.
• Advised Aurelius on its acquisition of What's Cooking Savoury Belgium NV.

Corporate advisory and reorganisation

• Advised an international pharmaceutical group on the governance aspects of their Belgian activities, including in light of a reorganisation of the group.